Eagle Pharmaceuticals (EGRX) Fails to deliver data

Key failure to deliver metrics for Eagle Pharmaceuticals :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €0 M
• Last 3 months FTD volume: €0.69 M
• Last year FTD volume: €0.69 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eagle Pharmaceuticals (EGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eagle Pharmaceuticals (EGRX) - since 2014

Eagle Pharmaceuticals (EGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	€70.18 M	€0.32 B	🇺🇸 USA
GlaxoSmithKline GSK	€25.89 M	€55.2 M	🇬🇧 UK
Novartis NVS	€22.57 M	€74.81 M	🇨🇭 Switzerland
Teva Pharmaceutical Industries TEVA	€9.38 M	€32.19 M	🇮🇱 Israel
Amgen AMGN	€48.74 M	€0.23 B	🇺🇸 USA
Eli Lilly LLY	€41.73 M	€0.14 B	🇺🇸 USA
Bristol-Myers Squibb BMY	€29.95 M	€0.31 B	🇺🇸 USA